Toxoplasmosis in Cats and the Risk of Brain Infection in Humans

Etiology and Life Cycle of Toxoplasma gondii

Toxoplasmosis is caused by the obligate intracellular protozoan parasite Toxoplasma gondii. The definitive hosts for T. gondii are members of the family Felidae, including domestic cats (Felis catus) and wild felids [1]. The parasite exhibits a complex life cycle involving sexual reproduction exclusively within the feline intestinal tract and asexual reproduction in a wide range of intermediate hosts, including mammals and birds [2]. The sexual phase occurs in the enterocytes of the feline small intestine, leading to the production of oocysts that are shed in the feces [3]. This process, known as the entero-epithelial cycle, is initiated when a cat ingests tissue cysts from an infected intermediate host [2]. Following ingestion, bradyzoites are released from tissue cysts and invade intestinal epithelial cells, where they undergo multiple rounds of asexual multiplication (merogony) before differentiating into male and female gametes (gametogony) [2]. Fertilization results in the formation of unsporulated oocysts, which are shed into the environment via cat feces [3]. A single cat can shed millions of oocysts, which sporulate and become infectious within one to five days under favorable environmental conditions [4]. The presence of T. gondii DNA in fecal samples from stray cats has been confirmed by PCR-based methods, underscoring the role of free-roaming felines in environmental contamination [4].

The asexual life cycle occurs in intermediate hosts, including humans, after ingestion of sporulated oocysts from contaminated environments or tissue cysts from undercooked meat [5]. Ingested sporozoites or bradyzoites transform into rapidly dividing tachyzoites, which disseminate throughout the body via the bloodstream and lymphatic system [6]. Tachyzoites invade nucleated cells, replicate within a parasitophorous vacuole, and cause cell lysis upon egress [6]. The immune response, particularly cell-mediated immunity, drives the conversion of tachyzoites into slowly replicating bradyzoites, which form tissue cysts predominantly in the brain, skeletal muscle, and myocardium [7]. These cysts persist for the lifetime of the host and represent a reservoir for potential reactivation [6].

Epidemiology of Feline Toxoplasmosis

Seroprevalence of T. gondii in domestic cats varies widely depending on geographic location, lifestyle, and sampling methodology. Studies have reported seroprevalence rates ranging from 30% to 60% in various regions [8, 9]. A study in Hong Kong found seroprevalence rates of 37.5% in privately-owned cats and 47.8% in community cats, with outdoor access identified as a significant risk factor [8]. In Jordan, a seroprevalence of 42.3% was reported in domestic cats, with risk factors including age, outdoor access, and raw meat consumption [9]. High seroprevalence rates have also been documented in wild felids, indicating widespread environmental exposure [1]. In urban informal settlements in Brazil, seroprevalence in companion animals, including cats, was associated with environmental degradation and social marginalization [10]. The presence of oocysts in cat feces, often referred to as toxoplasmosis in cat poop, is a critical epidemiological parameter. Molecular detection of T. gondii DNA in fecal samples from stray cats in Bangkok revealed a prevalence of 8.3%, confirming active shedding in the population [4]. The risk of human exposure is therefore directly linked to the density of free-roaming cats and the level of environmental contamination with sporulated oocysts [11].

Clinical Signs of Toxoplasmosis in Cats

Clinical toxoplasmosis in cats is relatively uncommon despite high seroprevalence, as most infections remain subclinical [12]. When disease does occur, it is often associated with immunosuppression, concurrent viral infections (e.g., feline immunodeficiency virus or feline leukemia virus), or young age [12]. The most frequently affected organ systems are the respiratory, gastrointestinal, and nervous systems. Ocular and neurological signs are particularly notable in cases of disseminated disease [12]. Neurological manifestations of cat toxoplasmosis brain involvement include ataxia, seizures, circling, behavioral changes, and cranial nerve deficits [12]. These signs result from the formation of necrotizing encephalitis and glial nodules, primarily in the cerebrum, cerebellum, and brainstem [6]. Ocular signs include uveitis, chorioretinitis, and optic neuritis [13]. Systemic signs may include fever, lethargy, anorexia, dyspnea, icterus, and pancreatitis [12]. The diagnosis of clinical toxoplasmosis in cats is challenging due to the non-specific nature of these signs and the high rate of subclinical seropositivity [12].

Risk of Brain Infection in Humans

The risk of human brain infection, or cerebral toxoplasmosis, is a major public health concern associated with T. gondii. In immunocompetent individuals, primary infection is typically asymptomatic or results in a mild, self-limiting febrile illness [7]. However, the parasite establishes a latent infection with tissue cysts in the brain, which can persist for decades [7]. In immunocompromised individuals, such as those with HIV/AIDS, organ transplant recipients, or those undergoing immunosuppressive therapy, reactivation of latent cysts can lead to severe, life-threatening encephalitis [6]. Cerebral toxoplasmosis in these patients presents with focal neurological deficits, seizures, altered mental status, and intracranial mass lesions visible on neuroimaging [6]. The pathogenesis involves the rupture of tissue cysts, release of bradyzoites, and uncontrolled replication of tachyzoites within the brain parenchyma, leading to necrotizing abscesses [6]. Even in immunocompetent populations, latent infection has been associated with subtle behavioral alterations and an increased risk of psychotic experiences, as well as changes in grey matter volume in specific brain regions [7]. The primary route of human infection is the ingestion of sporulated oocysts from contaminated soil, water, or food, or the ingestion of tissue cysts in undercooked meat [5]. Direct contact with cats is not considered a primary risk factor, as cats only shed oocysts for a short period (one to three weeks) after primary infection, and oocysts require sporulation to become infectious [14]. However, handling of cat litter boxes and poor hygiene practices can facilitate oocyst ingestion [14].

Diagnosis of Feline Toxoplasmosis

Diagnosis of toxoplasmosis in cats relies on a combination of serological, molecular, and histopathological methods. Serological detection of anti-T. gondii antibodies, particularly IgM and IgG, is the most common approach [15]. Commercial ELISA kits and indirect immunofluorescence assays are widely used for this purpose [15]. The detection of IgM antibodies suggests recent infection or reactivation, while IgG antibodies indicate past exposure [12]. A four-fold rise in IgG titers over a two to four week period is suggestive of active infection [12]. More recently, double-antigen sandwich colloidal gold immunochromatographic strips have been developed for rapid serological screening in multiple host species, including cats [15]. These point-of-care tests offer high sensitivity and specificity and are suitable for field use [15]. Similarly, SAG1-based immunochromatographic strips have been developed for swine and show promise for cross-species application [16].

Molecular detection of T. gondii DNA by polymerase chain reaction (PCR) is a highly sensitive and specific method for confirming active infection [17]. PCR can be performed on blood, aqueous humor, cerebrospinal fluid, bronchoalveolar lavage fluid, or tissue biopsies [17]. An antisense PCR assay has been developed specifically for detection in domestic cats, targeting the B1 gene or the 529 bp repeat element [17]. Fecal PCR is used to detect oocyst shedding, although the intermittent nature of shedding can lead to false negatives [4]. Histopathological examination of tissues, particularly the brain, can reveal characteristic tissue cysts and necrotizing lesions [18]. Immunohistochemistry using antibodies against T. gondii antigens can confirm the presence of the parasite in tissue sections [18]. The MIC17A antigen has been identified as a potential marker for both entero-epithelial and chronic stages of infection, offering a novel target for diagnostic development [12].

The following table summarizes the primary diagnostic methods for feline toxoplasmosis.

| Diagnostic Method | Target | Sample Type | Utility | | :-, | :-, | :-, | :-, | | Serology (ELISA, IFA) | Anti-T. gondii IgM/IgG | Serum, plasma | Screening, recent vs. past infection | | Immunochromatographic Strip | Anti-T. gondii antibodies | Serum, whole blood | Rapid field testing | | PCR (conventional, real-time, antisense) | T. gondii DNA (B1, 529 bp) | Blood, CSF, aqueous humor, feces | Active infection, oocyst shedding | | Histopathology / IHC | Tissue cysts, tachyzoites | Biopsy, necropsy tissue | Definitive diagnosis, lesion characterization |

Treatment and Clinical Management

Treatment of clinical toxoplasmosis in cats is indicated when there is evidence of active disease, such as neurological or ocular signs [12]. The standard therapeutic regimen involves a combination of clindamycin (an antibiotic with anti-protozoal activity) and an antifolate agent such as trimethoprim-sulfonamide [12]. Clindamycin is administered orally or intramuscularly at a dose of 10 to 12 mg/kg every 12 hours for a minimum of four weeks [12]. Pyrimethamine, in combination with a sulfonamide, is an alternative but is associated with a higher risk of adverse effects, including bone marrow suppression [12]. Corticosteroids may be used adjunctively to control inflammation in cases of severe ocular or neurological disease [12]. Supportive care, including fluid therapy, nutritional support, and anticonvulsants for seizure control, is essential [12]. Treatment does not eliminate tissue cysts, and recrudescence is possible if the cat becomes immunosuppressed [12].

Control and Prevention Strategies

Control of toxoplasmosis in cats and reduction of zoonotic risk to humans require a multi-faceted approach. Preventing cats from hunting intermediate hosts, such as rodents and birds, is a critical measure [8]. Feeding cats only commercially processed, cooked, or canned food eliminates the risk of ingesting tissue cysts [8]. Daily cleaning of litter boxes is recommended, as oocysts require one to five days to sporulate and become infectious [14]. Pregnant women and immunocompromised individuals should avoid handling cat litter if possible, or wear disposable gloves and wash hands thoroughly afterward [14]. Environmental contamination with oocysts can be reduced by confining cats indoors and managing stray cat populations [4]. The development of effective vaccines for cats remains an active area of research [19, 20]. Gene-edited live-attenuated vaccines have shown promise in preclinical studies, offering the potential to block oocyst shedding and prevent infection [19]. Advances in antigen discovery and mRNA vaccine platforms are also being explored within a One Health framework [20].

The following Mermaid diagram illustrates the key transmission pathways and intervention points for T. gondii.

flowchart TD
    A[Definitive Host: Cat], >|Ingests tissue cysts| B[Sexual Reproduction in Intestine]
    B, >|Shedding of oocysts| C[Environment: Soil, Water, Litter Box]
    C, >|Sporulation (1-5 days)| D[Infectious Oocysts]
    D, >|Ingestion by intermediate hosts| E[Intermediate Hosts: Rodents, Birds, Humans]
    E, >|Asexual reproduction, tissue cyst formation| F[Brain, Muscle, Other Tissues]
    F, >|Predation or scavenging| A
    D, >|Direct ingestion| G[Human Infection]
    G, >|Immunocompromised| H[Cerebral Toxoplasmosis]
    G, >|Immunocompetent| I[Latent Infection]
    I, >|Reactivation| H
    subgraph Intervention Points
        J[Feed cooked food, prevent hunting]
        K[Daily litter box cleaning]
        L[Vaccination of cats]
    end
    A, > J
    C, > K
    A, > L

Public Health Implications and One Health Perspective

Toxoplasmosis is a zoonotic disease with significant public health implications, particularly for pregnant women and immunocompromised individuals [21, 22]. Congenital transmission can occur if a woman acquires a primary infection during pregnancy, leading to miscarriage, stillbirth, or severe neonatal disease [21]. Seroprevalence studies in women with a history of abortion or stillbirth have identified T. gondii infection as a potential contributing factor [21]. Knowledge and practices regarding toxoplasmosis prevention among at-risk populations, such as pregnant women, are often inadequate, highlighting the need for targeted education [22, 23]. Veterinary professionals and students are also at increased risk due to occupational exposure to cats and their feces [24]. A One Health approach that integrates veterinary, medical, and environmental health disciplines is essential for effective surveillance, prevention, and control of toxoplasmosis [20]. This includes monitoring seroprevalence in animal reservoirs, reducing environmental contamination, and educating the public about risk factors [20, 5]. The role of cats as definitive hosts is central to the epidemiology of this parasite, and responsible pet ownership is a cornerstone of zoonotic risk reduction [14].

References

[1] Didkowska A, Kołodziej-Sobocińska M, Matusik K, et al. Toxoplasma gondii in wild felides in Poland. BMC Vet Res. 2025. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[2] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026.

[3] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026.

[4] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026.

[5] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026.

[6] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026.

[7] Jesuthasan J, Merritt K, Solmi F, et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026.

[8] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026.

[9] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026.

[10] Bazan L, Argibay HD, Borges-Silva W, et al. Seroprevalence and risk factors for Toxoplasma gondii infection in wild, domestic and companion animals in urban informal settlements from Salvador, Brazil. PLoS Negl Trop Dis. 2025.

[11] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026.

[12] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026.

[13] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP, et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026.

[14] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026.

[15] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026.

[16] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026.

[17] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026.

[18] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026.

[19] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026.

[20] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026.

[21] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026.

[22] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026.

[23] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026.

[24] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026.

[25] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026.

[26] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026.

[27] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026.

[28] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026.

[29] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026.

[30] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026.

[31] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026.

[32] Filho SCC, Moron SE, Ferreira RG, et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026.

[33] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026.

[34] Loeb J. Thrill seekers: how parasites change host behaviour. Vet Rec. 2026.

[35] Spada E, Tattarletti G, Proverbio D, et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025.